Literature DB >> 24790873

Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa?

Benjamin Longo-Mbenza1, Moise Mvitu Muaka2, Wayiza Masamba3, Lucien Muizila Kini4, Igor Longo Phemba5, Dalida Kibokela Ndembe6, Doris Tulomba Mona7.   

Abstract

AIM: To evaluate the rates of retinopathy without diabetes and diabetic retinopathy (DR), associated with some markers of oxidative stress, antioxidants and cardiometabolic risk factors.
METHODS: We determined the prevalence of DR in 150 type 2 diabetes mellitus (T2DM) patients, that of retinopathy in 50 non diabetics, the levels of body mass index (BMI), waist circumference (WC), blood pressure, lipids, 8-isoprostane, 8-hydroxydeoxyguanosine (8-OHdG), gamma-glutamyl transferase GT (GGT), oxidized low-density lipoprotein (OxLDL), thiobarbituric acid reacting substances (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), uric acid, creatinine, albumin, total antioxidant status (TAOS), zinc, selenium, magnesium, vitamin C, vitamin D, vitamin E, glucose, apolipoprotein B (ApoB).
RESULTS: The prevalences of DR at 53y and Rtp at 62y were 44% (n=66) and 10% (n=5), respectively. The highest levels of 8-isoprostane, 8-OHdG, TBARS, SOD, and OxLDL were in DR. The lowest levels of vitamin D, vitamin C, TAOS, and vitamin E were in DR. In the case-control study discriminant analysis, the levels of vitamin C, vitamin D, ApoB, 8-OHdG, creatinine, Zn, vitamin E, and WC distinguished significantly non-diabetics without DR (controls), T2DM patients without DR and T2DM patients with DR.
CONCLUSION: Anticipation of DR onset is significantly associated with the exageration of oxidative stress biomarkers or decrease of antioxidants in African type 2 diabetics. Prevention of oxidative stress and abdominal obesity is needed. Supplementation in vitamin C, D, and E should be recommended as complement therapies of T2DM.

Entities:  

Keywords:  Africa; anticipation; apolipoprotein B; diabetic retinopathy; discriminant analysis; oxidative stress

Year:  2014        PMID: 24790873      PMCID: PMC4003085          DOI: 10.3980/j.issn.2222-3959.2014.02.18

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  33 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

Review 2.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.

Authors:  Andina Hu; Yan Luo; Tao Li; Xiaobo Guo; Xiaoyan Ding; Xiaobo Zhu; Xueqin Wang; Shibo Tang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-12       Impact factor: 3.117

5.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

6.  1Alpha,25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats.

Authors:  Khaled Hamden; Serge Carreau; Kamel Jamoussi; Slaheddine Miladi; Samiha Lajmi; Dorra Aloulou; Fatma Ayadi; Abdelfattah Elfeki
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2009-06       Impact factor: 2.000

7.  Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity.

Authors:  K Arai; S Iizuka; Y Tada; K Oikawa; N Taniguchi
Journal:  Biochim Biophys Acta       Date:  1987-05-19

8.  Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.

Authors:  Mamta Kanwar; Pooi-See Chan; Timothy S Kern; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

9.  Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.

Authors:  Mohamed Al-Shabrawey; Sylvia Smith
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

10.  Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes.

Authors:  Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia J Jenkins; Jonathan Shaw; Carol Robinson; Jie Jin Wang
Journal:  Diabetes       Date:  2012-04-17       Impact factor: 9.461

View more
  5 in total

1.  Uric Acid and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Authors:  Yicong Guo; Siyue Liu; Huilan Xu
Journal:  Front Public Health       Date:  2022-05-31

2.  The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies.

Authors:  Bang-An Luo; Fan Gao; Lu-Lu Qin
Journal:  Nutrients       Date:  2017-03-20       Impact factor: 5.717

3.  Vitamin D3 Protects against Diabetic Retinopathy by Inhibiting High-Glucose-Induced Activation of the ROS/TXNIP/NLRP3 Inflammasome Pathway.

Authors:  Li Lu; Qianyi Lu; Wei Chen; Jingwen Li; Chunxia Li; Zhi Zheng
Journal:  J Diabetes Res       Date:  2018-02-22       Impact factor: 4.011

4.  Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress.

Authors:  Zeren Shen; Jinjin Shao; Jiabin Dai; Yuchen Lin; Xiaochun Yang; Jian Ma; Qiaojun He; Bo Yang; Ke Yao; Peihua Luo
Journal:  Toxicol Rep       Date:  2015-12-17

Review 5.  Dietary antioxidative supplements and diabetic retinopathy; a systematic review.

Authors:  Ozra Tabatabaei-Malazy; Edris Ardeshirlarijani; Nazli Namazi; Shekoufeh Nikfar; Reza Baradar Jalili; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.